Middle East's Hidden Stock Gems Include Drake and Scull International P.J.S.C

Yahoo

14-07-2025

In recent times, most Gulf markets have shown resilience, closing higher despite global tariff tensions, with indices like Dubai's hitting multi-year highs. This promising environment underscores the potential for discovering hidden stock gems in the Middle East, where companies like Drake and Scull International P.J.S.C. are gaining attention for their unique market positions amidst these dynamic conditions.
Name
Debt To Equity
Revenue Growth
Earnings Growth
Health Rating
Baazeem Trading
8.48%
-2.02%
-2.70%
★★★★★★
MOBI Industry
6.50%
5.60%
24.00%
★★★★★★
Saudi Azm for Communication and Information Technology
2.07%
16.18%
21.11%
★★★★★★
Sure Global Tech
NA
11.95%
18.65%
★★★★★★
Najran Cement
14.20%
-2.87%
-22.60%
★★★★★★
Nofoth Food Products
NA
15.75%
27.63%
★★★★★★
National General Insurance (P.J.S.C.)
NA
14.55%
29.05%
★★★★★☆
Etihad Atheeb Telecommunication
10.29%
36.24%
62.32%
★★★★★☆
National Corporation for Tourism and Hotels
19.25%
0.67%
4.89%
★★★★☆☆
National Environmental Recycling
69.43%
43.47%
32.77%
★★★★☆☆
Click here to see the full list of 222 stocks from our Middle Eastern Undiscovered Gems With Strong Fundamentals screener.
We'll examine a selection from our screener results.
Simply Wall St Value Rating: ★★★★☆☆
Overview: Drake and Scull International P.J.S.C. operates in the construction sector across various countries including the United Arab Emirates, Saudi Arabia, and others, with a market capitalization of approximately AED932.39 million.
Operations: Drake and Scull International P.J.S.C. generates revenue primarily from its wastewater treatment and water sludge segment, amounting to AED103.30 million.
Drake and Scull International (DSI) has shown a notable turnaround, reporting AED 2.45 million in net income for Q1 2025, compared to a net loss of AED 42.59 million the previous year, indicating significant profitability improvement. The company's price-to-earnings ratio is an attractive 0.2x against the AE market's 12.9x, suggesting potential undervaluation. Despite having more cash than total debt, DSI's earnings quality is impacted by a large one-off gain of AED3.8 billion over the past year. While free cash flow remains negative, positive shareholder equity marks progress from five years ago when it was negative.
Click here and access our complete health analysis report to understand the dynamics of Drake and Scull International P.J.S.C.
Gain insights into Drake and Scull International P.J.S.C's historical performance by reviewing our past performance report.
Simply Wall St Value Rating: ★★★★★★
Overview: Albaraka Türk Katilim Bankasi A.S. offers a range of banking products and services in Turkey, with a market capitalization of TRY21.20 billion.
Operations: Albaraka Türk Katilim Bankasi A.S. generates revenue primarily from its Commercial and Corporate segment, contributing TRY32.66 billion, followed by Treasury at TRY21.81 billion and Individual banking at TRY7.04 billion. The bank's business model focuses on these key segments to drive its financial performance in Turkey's banking sector.
Albaraka Türk Katilim Bankasi stands out with its robust financial health, boasting total assets of TRY352.5 billion and equity of TRY20.4 billion. The bank's earnings surged 159.8% over the past year, far outpacing the industry average of 0.8%. With a bad loans ratio at an appropriate 1.4% and a sufficient allowance for these loans at 163%, it shows prudent risk management. Additionally, 65% of its liabilities are sourced from low-risk customer deposits, reinforcing stability. Its price-to-earnings ratio sits attractively low at 1.7x compared to the TR market's 18x, suggesting potential undervaluation in current market conditions.
Take a closer look at Albaraka Türk Katilim Bankasi's potential here in our health report.
Review our historical performance report to gain insights into Albaraka Türk Katilim Bankasi's's past performance.
Simply Wall St Value Rating: ★★★★★★
Overview: Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi is a Turkish food company with a market capitalization of TRY21.02 billion.
Operations: Banvit generates revenue primarily from its food processing segment, amounting to TRY30.49 billion. The company's financial performance is reflected in its market capitalization of TRY21.02 billion.
Banvit, a notable player in the food industry, showcases some intriguing financial dynamics. Its earnings surged by 27% over the past year, outpacing the sector's -6.8% performance. The company enjoys robust debt management with cash exceeding total debt and interest payments comfortably covered by EBIT at ten times over. Despite these strengths, Banvit faces challenges such as a net loss of TRY 14.16 million in Q1 2025 compared to a significant profit last year and negative free cash flow trends persisting over recent years. Nonetheless, its price-to-earnings ratio of 7.9x suggests potential value relative to the broader market's 18x benchmark.
Get an in-depth perspective on Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi's performance by reading our health report here.
Assess Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi's past performance with our detailed historical performance reports.
Unlock our comprehensive list of 222 Middle Eastern Undiscovered Gems With Strong Fundamentals by clicking here.
Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include DFM:DSI IBSE:ALBRK and IBSE:BANVT.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email [e-mail]